Table 3.
Prognostic factors and significant textural parameters in univariate and multivariate Cox regression analysis of overall survival rate
| Univariate | Multivariate | |||
|---|---|---|---|---|
|
|
|
|||
| HR (95% CI) | P | HR (95% CI) | P | |
| Age (as continuous variable) | 0.98 (0.94-1.02) | 0.231 | ||
| FIGO stage III-IV | 1.53 (0.53-4.43) | 0.431 | ||
| PLN positive by PET | 1.65 (0.57-4.77) | 0.347 | ||
| PALN positive by PET | 1.50 (0.42-5.40) | 0.533 | ||
| ∆SUVmax decline < 30% | 1.78 (0.61-5.15) | 0.280 | ||
| ∆MTV decline < 60% | 2.29 (0.72-7.34) | 0.150 | ||
| ∆TLG decline < 60% | 4.70 (1.47-15.04) | 0.004 | 4.70 (1.47-15.04) | 0.009 |
| GLNU > 48 | 3.13 (1.05-9.38) | 0.031 | ||
| ∆RLNU decline < 55% | 3.68 (1.07-13.91) | 0.026 | ||
PLN pelvic lymph node, PALN para-aortic lymph node, SUVmax maximum standardized uptake value, MTV metabolic tumor volume, TLG total lesion glycolysis, GLNU gray-level nonuniformity, RLNU Run length nonuniformity.